Liver-Related Events in NASH (MASH): From Subgroup Stratification to Individual Risk Prediction

A new nomenclature for nonalcoholic fatty liver disease has been proposed recently as the result of a modified Delphi process led by 3 large pan-national liver associations (EASL, AASLD, ALEH).1 The term nonalcoholic fatty liver disease has been replaced with metabolic dysfunction-associated steatotic liver disease (MASLD), comprised in the overarching term steatotic liver disease (SLD). The term MASLD identifies the association of SLD with at least 1 of the 5 cardiometabolic risk factors, formerly identified as basic features of the metabolic syndrome.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research